CD8+ T cells specific for an immunodominant SARS-CoV-2 nucleocapsid epitope cross-react with selective seasonal coronavirusesKatie E. Lineburg, Stéphanie Gras, Emma J. Grant et al.|Immunity|2021Cited by 206
Epstein-Barr virus–specific T cell therapy for progressive multiple sclerosisMichael P. Pender, Rajiv Khanna, Peter A. Csurhes et al.|JCI Insight|2018Cited by 160
Autologous Adoptive T-cell Therapy for Recurrent or Drug-resistant Cytomegalovirus Complications in Solid Organ Transplant Recipients: A Single-arm Open-label Phase I Clinical TrialCorey Smith, Rajiv Khanna, Leone Beagley et al.|Clinical Infectious Diseases|2018Cited by 105
Pre-emptive and therapeutic adoptive immunotherapy for nasopharyngeal carcinoma: Phenotype and effector function of T cells impact on clinical responseCorey Smith, Rajiv Khanna, Dora L.�W. Kwong et al.|OncoImmunology|2017Cited by 72
Profiling HPV-16–specific T cell responses reveals broad antigen reactivities in oropharyngeal cancer patientsKunal H. Bhatt, Rajiv Khanna, Michelle A. Neller et al.|The Journal of Experimental Medicine|2020Cited by 64